Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium

被引：39

作者：

Kyung-Chul Choi

Nelly Auersperg

Peter CK Leung

机构：

[1] Department of Obstetrics/Gynaecology, BC Children's and Women's Hospital, University of British Columbia, Vancouver

来源：

Reproductive Biology and Endocrinology | / 1卷 / 1期

关键词：

MAPK; Ovarian cancer; Signaling pathway;

D O I：

10.1186/1477-7827-1-71

中图分类号：

学科分类号：

摘要：

Mitogen-activated protein kinases (MAPKs) are a group of serine/threonine kinases which are activated in response to a diverse array of extracellular stimuli and mediate signal transduction from the cell surface to the nucleus. It has been demonstrated that MAPKs are activated by external stimuli including chemotherapeutic agents, growth factors and reproductive hormones in ovarian surface epithelial cells. Thus, the MAPK signaling pathway may play an important role in the regulation of proliferation, survival and apoptosis in response to these external stimuli in ovarian cancer. In this article, an activation of the MAPK signaling cascade by several key reproductive hormones and growth factors in epithelial ovarian cancer is reviewed. © 2003 Choi et al; licensee BioMed Central Ltd.

引用

页数：8

共 38 条

[21]

Choi K.-C., Tai C.-J., Tzeng C.-R., Auersperg N., Leung P.C.K., Adenosine triphosphate (ATP) activates mitogen-activated protein kinases (MAPKs) in neoplastic ovarian surface epithelium (OSE) cells, Biol. Reprod., 68, pp. 309-315, (2003)

[22]

Baudhuin L.M., Cristina K.L., Lu J., Xu Y., Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific, Mol. Pharmacol., 62, pp. 660-671, (2002)

[23]

Wright J.W., Toth-Fejel S., Stouffer R.L., Rodland K.D., Proliferation of rhesus ovarian surface epithelial cells in culture: Lack of mitogenic response to steroid or gonadotropic hormones, Endocrinology, 143, pp. 2198-2207, (2002)

[24]

Venkatakrishnan G., Salgia R., Groopman J.E., Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells, J. Biol. Chem., 275, pp. 6868-6875, (2000)

[25]

Yazlovitskaya E.M., Pelling J.C., Persons D.L., Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101, Mol. Carcinog., 25, pp. 14-20, (1999)

[26]

Hayakawa J., Ohmichi M., Kurachi H., Ikegami H., Kimura A., Matsuoka T., Jikihara H., Mercola D., Murata Y., Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line, J. Biol. Chem., 274, pp. 31648-31654, (1999)

[27]

Gebauer G., Mirakhur B., Nguyen Q., Shore S.K., Simpkins H., Dhanasekaran N., Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells, Int. J. Oncol., 16, pp. 321-325, (2000)

[28]

Cui W., Yazlovitskaya E.M., Mayo M.S., Pelling J.C., Persons D.L., Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines, Mol. Carcinog., 29, pp. 219-228, (2000)

[29]

Mansouri A., Ridgway L.D., Korapati A.L., Zhang Q., Tian L., Wang Y., Siddik Z.H., Mills G.B., Claret F.X., Sustained activation of JNK-p38 MAP kinase pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells, J. Biol. Chem., (2003)

[30]

Seidman R., Gitelman I., Sagi O., Horwitz S.B., Wolfson M., The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells, Exp. Cell Res., 268, pp. 84-92, (2001)

← 1 2 3 4 →